Chemoprotection Effect of Multidrug Resistance 1 (MDR1) Gene Transfer to Hematopoietic Progenitor Cells and Engrafted in Mice with Cancer Allows Intensified Chemotherapy

REFERENCES

• Sorrentino B. P., Brandt S. J., Bodine D., Gottesman M., Pastan I., et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992; 257(5066)99–103, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Boesen J. J., Nooter K., Valerio D. Circumvention of chemotherapy-induced myelosuppression by transfer of the mdr1 gene. Biotherapy 1993; 6(4)291–302, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Sorrentino B. P., McDonagh K. T., Woods D., Orlic D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 1995; 86(2)491–501, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Schwarzenberger P., Spence S., Lohrey N., Kmiecik T., Longo D. L., et al. Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection. Blood 1996; 87(7)2723–2731, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hanania E. G., Deisseroth A. B. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther. 1994; 1(1)21–25, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ujhelly O., Ozvegy C., Varady G., Cervenak J., Homolya L., et al. Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells. Hum. Gene Ther. 2003; 14(4)403–412, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Klein C., Baum C. Gene therapy for inherited disorders of haematopoietic cells. Hematol. J. 2004; 5(2)103–111, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• May C., Rivella S., Callegari J., Heller G., Gaensler K. M., et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 2000; 406(6791)82–86, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pawliuk R., Westerman K. A., Fabry M. E., Payen E., Tighe R., et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 2001; 294(5550)2368–2371, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Levasseur D. N., Ryan T. M., Pawlik K. M., Townes T. M. Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood 2003; 102(13)4312–4319, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Persons D. A., Hargrove P. W., Allay E. R., Hanawa H., Nienhuis A. W. The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. Blood 2003; 101(6)2175–2183, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Imren S., Payen E., Westerman K. A., Pawliuk R., Fabry M. E., et al. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 2002; 99(22)14380–14385, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cassel A., Cottler-Fox M., Doren S., Dunbar C. E. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp. Hematol. 1993; 21(4)585–591, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hanawa H., Hematti P., Keyvanfar K., Metzger M. E., Krouse A., et al. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 2004; 103(11)4062–4069, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kay M. A., Glorioso J. C., Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. 2001; 7(1)33–40, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Podda S., Ward M., Himelstein A., Richardson C., de la Flor-Weiss E., et al. Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. USA 1992; 89(20)9676–9680, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S., Le Deist F., Carlier F., Bouneaud C., Hue C., et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 2002; 346(16)1185–1193, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Allsopp R. C., Weissman I. L. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role?. Oncogene 2002; 21(21)3270–3273, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ward M., Richardson C., Pioli P., Smith L., Podda S., et al. Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. Blood 1994; 84(5)1408–1414, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sawaoka H., Kawano S., Tsuji S., Tsujii M., Gunawan E. S., et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am. J. Physiol. 1998; 274(6 Pt. 1)G1061–G1067, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hanania E. G., Deisseroth A. B. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther. 1994; 1(1)21–25, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bunting K. D., Zhou S., Lu T., Sorrentino B. P. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 2000; 96(3)902–909, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Laufs S., Baum C., Fruehauf S. Transplantation of human hematopoietic progenitor cells transduced with a retroviral vector containing the human multidrug-resistance-1 gene for myeloprotective gene therapy. Transplant Proc. 2002; 34(6)2325–2329, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Demetri G. D., Griffin J. D. Hematopoietic growth factors and high-dose chemotherapy: will grams succeed where milligrams fail?. J. Clin. Oncol. 1990; 8(5)761–764, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jillella A. P., Ustun C. What is the optimum number of CD34(+) peripheral blood stem cells for an autologous transplant?. Stem Cells Dev. 2004; 13(6)598–606, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yannaki E., Athanasiou E., Xagorari A., Constantinou V., Batsis I., et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp. Hematol. 2005; 33(1)108–119, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bernardi R., Grisendi S., Pandolfi P. P. Modelling haematopoietic malignancies in the mouse and therapeutical implications. Oncogene 2002; 21(21)3445–3458, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Carpinteiro A., Peinert S., Ostertag W., Zander A. R., Hossfeld D. K., et al. Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice. Int. J. Cancer 2002; 98(5)785–792, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cowan K. H., Moscow J. A., Huang H., Zujewski J. A., O'Shaughnessy J., et al. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin. Cancer Res. 1999; 5(7)1619–1628, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mickisch G. H., Licht T., Merlino G. T., Gottesman M. M., Pastan I. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity. Cancer Res. 1991; 51(19)5417–5424, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Luskey B. D., Rosenblatt M., Zsebo K., Williams D. A. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 1992; 80(2)396–402, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bodine D. M., Karlsson S., Nienhuis A. W. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 1989; 86(22)8897–8901, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bunting K. D., Galipeau J., Topham D., Benaim E., Sorrentino B. P. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 1998; 92(7)2269–2279, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Licht T., Gottesman M. M., Pastan I. Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo. Cytokines Mol. Ther. 1995; 1(1)11–20, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• McLachlin J. R., Eglitis M. A., Ueda K., Kantoff P. W., Pastan I. H., et al. Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J. Natl. Cancer Inst. 1990; 82(15)1260–1263, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mickisch G. H., Merlino G. T., Galski H., Gottesman M. M., Pastan I. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc. Natl. Acad. Sci. USA 1991; 88(2)547–551, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hesdorffer C., Ayello J., Ward M., Kaubisch A., Vahdat L., , Phase I, et al. trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J. Clin. Oncol. 1998; 16(1)165–172, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ragg S., Xu-Welliver M., Bailey J., D'Souza M., Cooper R., et al. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells. Cancer Res. 2000; 60(18)5187–5195, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hanania E. G., Giles R. E., Kavanagh J., Fu S. Q., Ellerson D., et al. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc. Natl. Acad. Sci. USA 1996; 93(26)15346–15351, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar